GSNOR and ALDH2 alleviate traumatic spinal cord injury

[1]  Mushfiquddin Khan,et al.  Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke , 2020, Brain Research.

[2]  Yihai Cao,et al.  Aldehyde Dehydrogenase 2 Protects Against Post-Cardiac Arrest Myocardial Dysfunction Through a Novel Mechanism of Suppressing Mitochondrial Reactive Oxygen Species Production , 2020, Frontiers in Pharmacology.

[3]  G. Mohaddes,et al.  Sodium nitrate preconditioning prevents progression of the neuropathic pain in streptozotocin-induced diabetes Wistar rats , 2020, Journal of Diabetes & Metabolic Disorders.

[4]  Xu Yang,et al.  Endogenous formaldehyde is a memory-related molecule in mice and humans , 2019, Communications Biology.

[5]  Mushfiquddin Khan,et al.  S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[6]  Mushfiquddin Khan,et al.  Therapeutic exploitation of the S-nitrosoglutathione/S-nitrosylation mechanism for the treatment of contusion spinal cord injury , 2019, Neural regeneration research.

[7]  Y. Israel,et al.  Activation of mitochondrial aldehyde dehydrogenase (ALDH2) by ALDA-1 reduces both the acquisition and maintenance of ethanol intake in rats: A dual mechanism? , 2019, Neuropharmacology.

[8]  J. Stamler,et al.  Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione Reductase , 2019, Circulation.

[9]  Mengshan He,et al.  ALDH2 attenuates early‐stage STZ‐induced aged diabetic rats retinas damage via Sirt1/Nrf2 pathway , 2018, Life sciences.

[10]  S. Biswal,et al.  S-Nitrosoglutathione Reductase Is Essential for Protecting the Female Heart From Ischemia-Reperfusion Injury , 2018, Circulation research.

[11]  Mushfiquddin Khan,et al.  Amelioration of spinal cord injury in rats by blocking peroxynitrite/calpain activity , 2018, BMC Neuroscience.

[12]  R. Shi,et al.  Acrolein Contributes to the Neuropathic Pain and Neuron Damage after Ischemic–Reperfusion Spinal Cord Injury , 2018, Neuroscience.

[13]  N. Saxena,et al.  S‐nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis , 2018, Free radical biology & medicine.

[14]  Yan Li,et al.  ALDH2 Protects Against Ischemic Stroke in Rats by Facilitating 4-HNE Clearance and AQP4 Down-Regulation , 2018, Neurochemical Research.

[15]  Wen‐qi Huang,et al.  Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress , 2018, Free radical research.

[16]  L. Que,et al.  Effect of the S‐nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma , 2018, Immunity, inflammation and disease.

[17]  B. Ju,et al.  Mithramycin A Improves Functional Recovery by Inhibiting BSCB Disruption and Hemorrhage after Spinal Cord Injury. , 2017, Journal of neurotrauma.

[18]  H. Yao,et al.  Alda‐1 Protects Against Acrolein‐Induced Acute Lung Injury and Endothelial Barrier Dysfunction , 2017, American journal of respiratory cell and molecular biology.

[19]  Chen Zhang,et al.  Increased GSNOR Expression during Aging Impairs Cognitive Function and Decreases S-Nitrosation of CaMKIIα , 2017, The Journal of Neuroscience.

[20]  N. Vij,et al.  Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function. , 2017, Antioxidants & redox signaling.

[21]  Hai-rong Tao,et al.  Aldehyde dehydrogenase 2 overexpression inhibits neuronal apoptosis after spinal cord ischemia/reperfusion injury , 2017, Neural regeneration research.

[22]  G. Guízar-Sahagún,et al.  Methylprednisolone Administration Following Spinal Cord Injury Reduces Aquaporin 4 Expression and Exacerbates Edema , 2017, Mediators of inflammation.

[23]  Mushfiquddin Khan,et al.  Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats , 2015, Journal of Neuroinflammation.

[24]  Mushfiquddin Khan,et al.  Promoting endothelial function by S-nitrosoglutathione through the HIF-1α/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in rats , 2015, Drug design, development and therapy.

[25]  B. Liu,et al.  Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury. , 2014, Current drug targets.

[26]  S. Mutka,et al.  Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation , 2014, BMC Pulmonary Medicine.

[27]  Julio C. B. Ferreira,et al.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. , 2014, Physiological reviews.

[28]  Sourabh Kharait,et al.  Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo. , 2013, Journal of applied physiology.

[29]  Mushfiquddin Khan,et al.  The inhibitory effect of S‐nitrosoglutathione on blood–brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke , 2012, Journal of neurochemistry.

[30]  G. Rosenthal,et al.  Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase. , 2012, Biochemistry.

[31]  D. Colagiovanni,et al.  A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma. , 2012, Regulatory toxicology and pharmacology : RTP.

[32]  Adem Can,et al.  The mouse forced swim test. , 2011, Journal of visualized experiments : JoVE.

[33]  J. Stamler,et al.  Regulation by S-Nitrosylation of Protein Post-translational Modification* , 2011, The Journal of Biological Chemistry.

[34]  M. Bilgen,et al.  Preclinical use of longitudinal MRI for screening the efficacy of s‐nitrosoglutathione in treating spinal cord injury , 2011, Journal of magnetic resonance imaging : JMRI.

[35]  S. Mutka,et al.  Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases. , 2011, ACS medicinal chemistry letters.

[36]  A. Faden,et al.  A combined scoring method to assess behavioral recovery after mouse spinal cord injury , 2010, Neuroscience Research.

[37]  D. Mochly‐Rosen,et al.  Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant , 2010, Nature Structural &Molecular Biology.

[38]  Mushfiquddin Khan,et al.  Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact , 2009, Journal of Neuroinflammation.

[39]  E. Hall,et al.  Temporal and spatial dynamics of peroxynitrite-induced oxidative damage after spinal cord contusion injury. , 2009, Journal of neurotrauma.

[40]  R. Grafström,et al.  The Janus face of alcohol dehydrogenase 3. , 2009, Chemico-biological interactions.

[41]  E. Hall,et al.  Pharmacological evidence for a role of peroxynitrite in the pathophysiology of spinal cord injury , 2009, Experimental Neurology.

[42]  E. Hall,et al.  Peroxynitrite‐mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers , 2007, Journal of neuroscience research.

[43]  R. Shi,et al.  Acrolein‐mediated mechanisms of neuronal death , 2006, Journal of neuroscience research.

[44]  Aileen J Anderson,et al.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. , 2006, Journal of neurotrauma.

[45]  Mehmet Bilgen,et al.  A New Device for Experimental Modeling of Central Nervous System Injuries , 2005, Neurorehabilitation and neural repair.

[46]  Yi Dai,et al.  Role of Mitogen-Activated Protein Kinase Activation in Injured and Intact Primary Afferent Neurons for Mechanical and Heat Hypersensitivity after Spinal Nerve Ligation , 2004, The Journal of Neuroscience.

[47]  H. Markus,et al.  S-nitrosoglutathione reduces the rate of embolization in humans. , 1998, Circulation.